- Prasterone Monograph (Alternative Medicine Review) (2001)
- DrugDex™ Summary
- Dehydroepiandrosterone for Systemic Lupus Erythematosus, The Cochrane Review (2010)
- Schlienger, J.L. et al., DHEA: Célèbre et Méconnu (DHEA: Little-Known Star), Rev Méd Interne (2002) 23:436-446
- Formulary Review: Prasterone, Amer J Health Sys Pharm 63: 2201-2212 (2006)
- Adverse Events / Reactions
- Drug Interactions
Congratulations; your decision to visit this site shows that you are concerned with your health, and with the health of those close to you.
We use this site to provide you with a comprehensive resource on prasterone research. We discuss research by teams affiliated with some of the leading medical research institutions: Stanford University, Johns Hopkins University, Northwestern University and others. Here, you’ll find the results of several randomized, large-scale, placebo-controlled, double-blind Phase III clinical studies – studies which evaluate prasterone for a number of clinical indications. You may, like many others, decide to discuss this research with your health care provider, to decide if prasterone could be beneficial for you.
A way to assure that your prasterone is pure is to ask your health care provider to prescribe a dosage form compounded by your pharmacist. Please note that prasterone may have variable or poor oral bioavailability when administered as an oral tablet.
A prescription-strength prasterone pharmaceutical product for is currently un+der development for lupus and osteoporosis. To find out when it is released commercially, join our mailing list